Company Filing History:
1 out of 291 
1 out of 76 
Years Active: 2017
Title: Marion J Kennedy: Innovator in Hematopoietic Stem Cell Research
Introduction
Marion J Kennedy is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of stem cell research, particularly in the area of hematopoietic progenitors. Her innovative work has led to advancements in methods for enriching stem cells, which are crucial for various medical applications.
Latest Patents
Marion J Kennedy holds a patent titled "Populations of hematopoietic progenitors and methods of enriching stem cells therefor." This patent describes a method for enriching a population of stem cells for hematopoietic progenitors. The method involves inducing hematopoietic differentiation in human embryonic stem cells or human induced pluripotent stem cells. It includes sorting the population based on the expression of CD43 and at least one of CD34, CD31, and CD144. The process selects a fraction that is at least one of CD34+CD43−, CD31+CD43−, and CD144+CD43−. Additionally, the patent provides populations of hematopoietic progenitors obtained through these methods.
Career Highlights
Throughout her career, Marion J Kennedy has worked with esteemed institutions such as the University Health Network and Sunnybrook Research Institute. Her research has focused on enhancing the understanding and application of stem cell technology, which has the potential to revolutionize treatments for various diseases.
Collaborations
Marion has collaborated with notable colleagues in her field, including Gordon Keller and Juan Carlos Zuniga-Pflucker. These partnerships have contributed to her innovative research and the advancement of stem cell methodologies.
Conclusion
Marion J Kennedy is a trailblazer in the field of hematopoietic stem cell research. Her patent and collaborative efforts have significantly impacted the scientific community and hold promise for future medical advancements.